𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Two new mutations in the HIF2A gene associated with erythrocytosis

✍ Scribed by Melanie J. Percy; Yu Jin Chung; Claire Harrison; Jane Mercieca; A. Victor Hoffbrand; Carla L. Dinardo; Paulo C.J.L. Santos; Guilherme H.H. Fonseca; Sandra F.M. Gualandro; Alexandre C. Pereira; Terence R.J. Lappin; Mary Frances McMullin; Frank S. Lee

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
928 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Congenital or familial erythrocytosis/polycythemia can have many causes, and an emerging cause is genetic disruption of the oxygen‐sensing pathway that regulates the Erythropoietin (EPO) gene. More specifically, recent studies have identified erythrocytosis‐associated mutations in the HIF2A gene, which encodes for Hypoxia Inducible Factor‐2α (HIF‐2α), as well as in two genes that encode for proteins that regulate it, Prolyl Hydroxylase Domain protein 2 (PHD2) and the von Hippel Lindau tumor suppressor protein (VHL). We report here the identification of two new heterozygous HIF2A missense mutations, M535T, and F540L, both associated with erythrocytosis. Met‐535 has previously been identified as a residue mutated in other patients with erythrocytosis; although, the mutation of this particular residue to Thr has not been reported. In contrast, Phe‐540 has not been reported as a residue mutated in erythrocytosis, and we present evidence here that this mutation impairs interaction of HIF‐2α with both VHL and PHD2. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Association of two mutations in the CHEK
Association of two mutations in the CHEK2 gene with breast cancer
✍ Natalia Bogdanova; Natalia Enβen-Dubrowinskaja; Sergei Feshchenko; Gennady I. La 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 148 KB 👁 2 views

## Abstract The 1100delC mutation of the cell cycle checkpoint kinase 2 (__CHEK2__) gene confers an increased risk for breast cancer, but the clinical impact of other __CHEK2__ gene variants remains unclear. We determined the frequency of two functionally relevant __CHEK2__ gene mutations, I157T an

A new mtDNA mutation in the tRNALeu(UUR)
A new mtDNA mutation in the tRNALeu(UUR) gene associated with maternally inherited cardiomyopathy
✍ G. Silvestri; F. M. Santorelli; S. Shanske; C. B. Whitley; L. A. Schimmenti; S. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 897 KB

## Communicated by N m n Arnheim We report a new mutation, a C to T transition at nt 3303 of mtDNA, in seven members of a family with cardiomyopathy and myopathy: the proband and two siblings had fatal infantile cardiomyopathy, whereas in three maternal relatives the disease manifested later in li

A missense mutation in the OCTN2 gene as
A missense mutation in the OCTN2 gene associated with residual carnitine transport activity
✍ Yuhuan Wang; Michelle A. Kelly; Tina M. Cowan; Nicola Longo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation caused by defective carnitine transport. This disease can present early in life with hypoketotic hypoglycemia and acute metabolic decompensation, or later in life with skeletal or cardiac myopathy. Mutations abol